Works by Pönisch, W.


Results: 12
    1
    2

    Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2006, v. 132, n. 4, p. 205, doi. 10.1007/s00432-005-0074-4
    By:
    • Pönisch, W.;
    • Mitrou, P.;
    • Merkle, K.;
    • Herold, M.;
    • Assmann, M.;
    • Wilhelm, G.;
    • Dachselt, K.;
    • Richter, P.;
    • Schirmer, V.;
    • Schulze, A.;
    • Šubert, R.;
    • Harksel, B.;
    • Grobe, N.;
    • Stelzer, E.;
    • Schulze, M.;
    • Bittrich, A.;
    • Freund, M.;
    • Pasold, R.;
    • Friedrich, Th.;
    • Helbig, W.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission.

    Published in:
    Leukemia (08876924), 2009, v. 23, n. 4, p. 635, doi. 10.1038/leu.2008.352
    By:
    • Basara, N.;
    • Schulze, A.;
    • Wedding, U.;
    • Mohren, M.;
    • Gerhardt, A.;
    • Junghanss, C.;
    • Peter, N.;
    • Dölken, G.;
    • Becker, C.;
    • Heyn, S.;
    • Kliem, C.;
    • Lange, T.;
    • Krahl, R.;
    • Pönisch, W.;
    • Fricke, H.-J.;
    • Sayer, H. G.;
    • Al-Ali, H.;
    • Kamprad, F.;
    • Niederwieser, D.
    Publication type:
    Article
    11
    12